Stay updated on Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Record History shows recruitment-status updates across multiple versions: 2018-07-17, 2021-08-03, and 2025-08-21. These changes reflect shifts in the study's enrollment status.
    Difference
    0.1%
    Check dated 2025-11-02T00:56:06.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Added a government-operation notice and version bump to v3.2.0; removed reference to v3.1.0. The page now informs users about potential processing delays and where to check status, reflecting an operational update.
    Difference
    13%
    Check dated 2025-10-04T12:18:53.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not alter core content or other critical info.
    Difference
    0.3%
    Check dated 2025-09-27T07:38:14.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.1 to v3.0.2 and removed the Back to Top element. This is a minor metadata/UX change with no impact on core content, pricing, stock, or time slots.
    Difference
    0.8%
    Check dated 2025-09-13T01:42:46.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.8%
    Check dated 2025-09-05T19:50:54.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.
    Difference
    8%
    Check dated 2025-08-29T18:40:07.000Z thumbnail image

Stay in the know with updates to Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pyrotinib + Trastuzumab in HER2+ Breast Cancer Clinical Trial page.